Co-led Kanvas Biosciences' $48M Series A for microbiome therapeutics.
Kanvas Biosciences is focused on illuminating microbial life and developing novel microbial therapeutics through advanced imaging tools and a vertically-integrated technology platform
Kanvas Biosciences is focused on illuminating microbial life and developing novel microbial therapeutics through advanced imaging tools and a vertically-integrated technology platform.